Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Kodiak Sciences
KOD
$2.88B
| $3.73M | ﹤0.01% |
68,831
+12,139
| +21% | +$685K |
|
2927
Varonis Systems
VRNS
$4.86B
| $3.71M | ﹤0.01% |
125,715
-10,257
| -8% | -$257K |
|
|
CIVI
2928
DELISTED
Civitas Resources
CIVI
| $3.7M | ﹤0.01% |
249,967
-195,110
| -44% | -$3.18M |
|
2929
RPC Inc
RES
$1.31B
| $3.7M | ﹤0.01% |
1,201,117
-358,182
| -23% | -$1.09M |
|
|
ORTX
2930
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.7M | ﹤0.01% |
61,611
+60,955
| +9,292% | +$5.58M |
|
|
BCV
2931
Bancroft Fund
BCV
$137M
| $3.68M | ﹤0.01% |
154,450
-10,035
| -6% | -$222K |
|
2932
Franklin Investment Grade Corporate ETF
FLCO
$555M
| $3.68M | ﹤0.01% |
138,884
-50,363
| -27% | -$1.29M |
|
|
RCS
2933
PIMCO Strategic Income Fund
RCS
$248M
| $3.68M | ﹤0.01% |
577,020
-35,405
| -6% | -$232K |
|
|
VSLR
2934
DELISTED
VIVINT SOLAR, INC.
VSLR
| $3.68M | ﹤0.01% |
371,339
+94,664
| +34% | +$681K |
|
2935
Golub Capital BDC
GBDC
$3.4B
| $3.67M | ﹤0.01% |
315,455
-148
| -0% | -$1.67K |
|
2936
Abercrombie & Fitch
ANF
$4.93B
| $3.67M | ﹤0.01% |
345,445
+111,194
| +47% | +$1.21M |
|
2937
iShares Global Utilities ETF
JXI
$309M
| $3.67M | ﹤0.01% |
68,932
-2,940
| -4% | -$155K |
|
2938
Baytex Energy
BTE
$2.93B
| $3.67M | ﹤0.01% |
7,281,781
-14,285,429
| -66% | -$5.13M |
|
2939
Groupon
GRPN
$980M
| $3.67M | ﹤0.01% |
202,749
+63,647
| +46% | +$1.42M |
|
|
NGM
2940
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.66M | ﹤0.01% |
185,521
+182,634
| +6,326% | +$3.49M |
|
2941
Coeur Mining
CDE
$16.4B
| $3.66M | ﹤0.01% |
720,264
-63,233
| -8% | -$288K |
|
2942
Strategy Inc
MSTR
$37.2B
| $3.66M | ﹤0.01% |
309,440
+18,150
| +6% | +$221K |
|
|
CADE
2943
DELISTED
Cadence Bancorporation
CADE
| $3.66M | ﹤0.01% |
412,824
-23,717
| -5% | -$169K |
|
2944
OSI Systems
OSIS
$3.93B
| $3.66M | ﹤0.01% |
48,995
-81,319
| -62% | -$5.94M |
|
2945
Geron
GERN
$1.01B
| $3.65M | ﹤0.01% |
1,675,874
+1,572,521
| +1,522% | +$2.35M |
|
|
NCZ
2946
Virtus Convertible & Income Fund II
NCZ
$299M
| $3.65M | ﹤0.01% |
233,471
+5,691
| +2% | +$81.9K |
|
|
LM
2947
DELISTED
Legg Mason, Inc.
LM
| $3.64M | ﹤0.01% |
73,235
-3,619
| -5% | -$180K |
|
2948
Simulations Plus
SLP
$371M
| $3.64M | ﹤0.01% |
60,867
+32,725
| +116% | +$1.44M |
|
|
LSXMA
2949
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.64M | ﹤0.01% |
143,494
-116,255
| -45% | -$2.84M |
|
2950
iShares MSCI Chile ETF
ECH
$1.07B
| $3.64M | ﹤0.01% |
144,405
+1,252
| +0.9% | +$31K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.